مدونة صيدلاوى

Varenicline (Champix) for smoking cessation – changed note to restriction 1 Dec 2014 From 1 October 2014 the NOTE to the PBS listing for varenicline tartrate (0.5 mg [11 tablets] plus 1 mg [42 tablets], 53 tablets total; and 1 mg [56 tablets]) has changed to permit another course of varenicline (instead of bupropion) in patients who did not stop smoking after an initial 12- or 24-week treatment course, provided that 6 months have elapsed between starting the previous course of varenicline and the subsequent course.1 Previously, only one course (12 or 24 weeks) of varenicline was PBS subsidised in any 12-month period. PBS listing Varenicline is currently PBS listed for short-term (12 or 24 week), sole PBS-subsidised therapy as an aid to achieving abstinence in a patient who has indicated they are ready to stop smoking. Initial treatment is for 12 weeks, and for those who have abstained from smoking, an additional 12 weeks of treatment may be undertaken. Patien...

معلومة هامة يجب على جميع الصيادلة معرفتها: جميع مضادات الاكتئاب المانعة لارتجاع السيروتونين Serotonin Reuptake Inhibitors باستثناء الFluoxetine يجب أن لا يتم توقيفها بشكل مفاجئ وإنما بشكل تدريجي على فترة اسبوعين ل4 أسابيع لأنها تسبب أعراض انسحابية Withdrawal symptoms الآثار الجانبية المترافقة مع التوقف المفاجئ هي: أعراض شبيهة بالانفلونزا Flu like symptoms دوخة Dizziness غثيان Nausea رجفان Tremor قلق Anxiety رجفان قلبي Palpitation السبب أن الفلوكسيتين(بروزاك) لا يسبب اعراض انسحابية هو تأثيره المديد حيث يبقى الدواء في الجسم لمدة طويلة ويتم طرحه بشكل تدريجي.   عرض المشاركات المصنفة بحسب مدى الصلة بالموضوع لطلب البحث Withdrawal . تصنيف بحسب التاريخ عرض كل المشاركات Nalufin How should to take diazepam   Drug addiction   Drug addiction   معلومة هامة يجب على جميع الصيادلة معرفتها:Serotonin Reuptake Inhibitors   Chronic Constipation   Abilify2.sideeffect..!!!

Nalufin Nalufin ampules image  Composition: Each ampoule 1ml contains: Nalbuphine Hydrochloride 20mg Properties: -    Nalufin ® (Nalbuphine Hydrochloride) is a synthetic narcotic agonist-antagonist analgesic of the phenanthrene series. -    Nalufin ® (Nalbuphine Hydrochloride) is a potent analgesic. Its analgesic potency is essentially equivalent to that of morphine on a milligram basis. -    The onset of action of Nalufin ® (Nalbuphine Hydrochloride) occurs within 2-3 minutes after intravenous administration, and in less than 15 minutes following subcutaneous or intramuscular injection. The plasma half-life of Nalbuphine is 5 hours, and the duration of analgesic activity has been reported to range from 3 to 6 hours. Indications: -    Relief of moderate to severe pain, including that associated with myocardial infarction, cancer, ...

Abstract Background:  Chronic constipation is a common condition seen in family practice among the elderly and women. There is no consensus regarding its exact definition, and it may be interpreted differently by physicians and patients. Physicians prescribe various treatments, and patients often adopt different over-the-counter remedies. Chronic constipation is either caused by slow colonic transit or pelvic floor dysfunction, and treatment differs accordingly. Methods:  To update our knowledge of chronic constipation and its etiology and best-evidence treatment, information was synthesized from articles published in PubMed, EMBASE, and Cochrane Database of Systematic Reviews. Levels of evidence and recommendations were made according to the Strength of Recommendation taxonomy. Results:  The standard advice of increasing dietary fibers, fluids, and exercise for relieving chronic constipation will only benefit patients with true deficiency. Biofeedback works best fo...

SIDE EFFECTS Overall Adverse Reactions Profile The following are discussed in more detail in other sections of the labeling: Use in Elderly Patients with Dementia-Related Psychosis [see BOXED WARNING and WARNINGS AND PRECAUTIONS ] Clinical Worsening of Depression and Suicide Risk [see BOXED WARNING and WARNINGS AND PRECAUTIONS ] Neuroleptic Malignant Syndrome (NMS) [see WARNINGS AND PRECAUTIONS ] Tardive Dyskinesia [see WARNINGS AND PRECAUTIONS ] Hyperglycemia and Diabetes Mellitus [see WARNINGS AND PRECAUTIONS ] Orthostatic Hypotension [see WARNINGS AND PRECAUTIONS ] Leukopenia , Neutropenia , and Agranulocytosis [see WARNINGS AND PRECAUTIONS ] Seizures/Convulsions [see WARNINGS AND PRECAUTIONS ] Potential for Cognitive and Motor Impairment [see WARNINGS AND PRECAUTIONS ] Body Temperature Regulation [see WARNINGS AND PRECAUTIONS ] Suicide [see WARNINGS AND PRECAUTIONS ] Dysphagia [see WARNINGS AND PRECAUTIONS ] Use in Patients with Concomitant Illness [see WARNINGS AND ...